Oscar Health, Inc. (OSCR) shares plummeted by 5.08% on Thursday morning during the trading session, underperforming the broader market.
Bank of America Securities analyst Adam Ron reiterated a "Sell" rating on Oscar Health and set a relatively low price target, reflecting concerns over the company's recent performance and outlook.
The analyst's downgrade was driven by Oscar Health's revenue miss and potential risks surrounding its enrollment numbers. The company's ability to attract and retain customers is crucial for its growth and profitability, and any challenges in this area could weigh heavily on its stock.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。